1. A Time for Change for Managing Patients With VTE Who Have Cancer

2. Challenges of VTE in Cancer

3. Hokusai VTE-Cancer

4. Hokusai-VTE Cancer: Study Design

5. Hokusai VTE-Cancer: Clinical Outcomes

6. Hokusai VTE-Cancer: Types of Major Bleeds Contributing to Primary Outcome

7. Hokusai VTE-Cancer: Duration of Study Drug Treatment

8. Hokusai VTE-Cancer: Reasons for Study Drug Discontinuation

9. US Prescription Patterns for Cancer-Associated VTE

10. Potential Clinical Implications of Hokusai VTE-Cancer Study

11. Hokusai VTE-Cancer

12. Clinical Value of Composite Endpoint in Hokusai VTE-Cancer

13. Interpretation of Clinical Outcomes

14. GI Bleeding

15. Treatment and Secondary Prevention Strategy for VTE in Patients With Active Cancer

16. Hokusai VTE-Cancer

17. Relevance of NOACs in Cancer-Associated VTE

18. Efficacy and Safety of NOACs in Cancer vs No Cancer

19. Addressing the Use of NOACs in Patients With Cancer

20. Limitations of Managing VTE in South America

21. Strengths and Limitations of Hokusai VTE-Cancer

22. Abbreviations